RAY1225
Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin
Guangdong Raynovent Biotech Co · Phase 1 · Active, not recruiting · Enrollment 32
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Experimental 1 | n/r | n/r | n/r | n/r |
Not shown
- Experimental 1: endpoint not reported